Brinkmann Volker, Lynch Kevin R
Novartis Pharma AG Transplantation Research WSJ-386.101, CH-4002 Basel, Switzerland.
Curr Opin Immunol. 2002 Oct;14(5):569-75. doi: 10.1016/s0952-7915(02)00374-6.
The novel immunomodulator FTY720 is remarkably effective in models of transplantation and autoimmunity. Recent data show that phosphorylated FTY720 is an agonist at four sphingosine 1-phosphate receptors. Stimulation of sphingosine 1-phosphate receptors leads to sequestration of lymphocytes in secondary lymphatic tissues and thus away from inflammatory lesions and graft sites.